Header Logo

Connection

JONATHAN LEI to Piperazines

Back to Details
This is a "connection" page, showing publications JONATHAN LEI has written about Piperazines.
JONATHAN LEI
Connection Strength
0.053
Piperazines
  1. PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. Mol Cancer Ther. 2024 Oct 01; 23(10):1494-1510.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.